Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

FPA Queens Road Small Cap Value Fund 2026 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (FPA Queens Road Small Cap Value Fund)

Primary Source Intelligence • Q3 2026 Letter Analysis

FPA Queens Road Small Cap Value Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, FPA Queens Road Small Cap Value Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

QTD-7.62%

YTD+17.35%

Annualized+10.04%

Positioning StanceCONSTRUCTIVE

Market CapSmallCap

GeographyUS

Digest Analysis

Quick Take

"FPA Queens Road Small Cap Value Fund returned -7.62% net in 3Q 2026, trailing the benchmark due to lack of biotech and energy exposure, while deploying capital into five neglected value compounders and maintaining 10.3% cash."

Executive Summary

The FPA Queens Road Small Cap Value Fund returned -7.62% net of fees in the third quarter of 2026, trailing the Russell 2000 Value Index return of -4.91%. Year-to-date through September 30, 2026, the Fund returned 17.35% net of fees, outpacing the benchmark's 16.96% net return. Fund underperformance during the third quarter was primarily driven by zero exposure to energy and biotech-heavy healthcare, alongside cyclical weakness across consumer discretionary holdings in apparel and automotive retail. Cash and short-term Treasury ETF reserves stood at 10.3% of the portfolio at quarter-end. The investment team maintains a disciplined, fundamental framework amid broader market froth, arguing that recent small-cap index strength represents a speculative lottery driven by unprofitable companies, biotech momentum, and artificial intelligence hype rather than a broad-based valuation rerating. In contrast, profitable, high-quality small businesses continue to trade at significant valuation discounts to large caps and private equity transactions, presenting attractive long-term entry points for patient capital. Portfolio activity during the quarter centered on rotating proceeds from highly appreciated technology suppliers exposed to the AI trade into unloved, economically sound compounders. The Fund initiated five new positions: Hayward Holdings, Teleflex, Simpson Manufacturing, FTI Consulting, and Flowco, while completely exiting Everus Construction on valuation. In addition, the managers trimmed appreciated holdings in TD Synnex, Arrow Electronics, Vishay Intertechnology, and Littelfuse following substantial cyclical run-ups.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

65%

CautiousHigh

Moderate (65%)

Market Conviction

The portfolio managers hold a diversified portfolio with 10.3% cash while maintaining significant co-investment capital in the fund. Holdings are sized systematically, and management demonstrated decisive discipline by trimming strong performers in technology and deploying capital into five new positions.

40%

BearishBullish

Neutral (40%)

Growth Outlook

Management characterizes broader markets as exhibiting froth, excess, and lottery-like speculation concentrated in loss-making story stocks. While constructive on select profitable small caps, their outlook remains cautious regarding prevailing market enthusiasm.

50%

DefensiveAggressive

Balanced (50%)

Risk Appetite

Positioning balances active capital deployment with a defensive 10.3% cash reserve and avoidance of speculative biotech and high-multiple technology equities. The team prefers non-discretionary, cash-flow-generative compounders over aggressive risk-taking.

60%

De-riskingDeploying

Net Neutral (60%)

Capital Deployment

The fund deployed capital into five new common stock additions and selectively added to existing holdings on earnings weakness. However, net deployment was balanced by significant profit-taking in technology holdings and an exit in Everus, keeping cash at 10.3%.

70%

CautiousExpansionary

Expansionary (70%)

Forward Guidance

The managers are actively initiating starting positions in neglected businesses at roughly 11x to 15x earnings while continuing to trim highly appreciated holdings. They maintain an explicit deployment bias toward boring, cash-generative small caps overlooked by the AI trade.

55%

BearishBullish

Balanced (55%)

Language Signal

The narrative balances warning terms such as froth, excess, speculation, and expensive against constructive language regarding attractive entry prices, low multiples, and strong business quality. The net directional tone is moderately constructive toward quality value.

65%

Low RiskElevated

Elevated Risk (65%)

Perceived Risk

The managers emphasize elevated environmental risks including interest rate pressures, housing market stagnation, high private equity leverage, tariff volatility, and market-wide speculative excesses. They explicitly position against these hazards via contra-cyclical business models.

65%

ScarceAbundant

Abundant (65%)

Opportunity Density

While acknowledging that quality small caps are not dirt cheap, the managers successfully identified five new positions during the quarter. Opportunities are viewed as rich within boring, unhyped sectors even as the broader index remains distorted by speculative segments.

85%

Short-TermLong-Term

Decade+ (85%)

Time Horizon

Management explicitly urges investors to evaluate performance across a full market cycle rather than quarter-to-quarter. Their fundamental thesis relies on multi-year business compounding and long-term mean reversion rather than near-term catalyst trading.